Products for Research Use Only
RegisterLogin

WEHI-P8

CAT: 0013-GTR19258099-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19258099-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease (PLpro) . It inhibits SARS-CoV-2 PLpro with an IC50 of 12 nM and demonstrates excellent cellular activity with an EC50 of 298 nM. Additionally, WEHI-P8 has protective effects in mice against prolonged lung and brain symptoms caused by SARS-CoV-2. This compound is applicable for research on post-COVID-19 syndrome.
Field of Research
Infectious Disease & Virology
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19189153WEHI-345
GTR19163761-01WEHI-345
GTR19205002WEHI-539
GTR19186015-01WEHI-150
GTR19264497-01WEHI-326
GTR19226894-01WEHI-9625
GTR19258727-01WEHI-3773
GTR19205024-01WEHI-345 analog
GTR19189722Desmethyl-WEHI-345 analog
GTR18316438COM1/p8 Antibody

Alternative Products

CatalogName
HY-172350WEHI-P8
BA3493-10WEHI-345
HY-128777-01WEHI-9625
HY-175362WEHI-326
T62582-01WEHI-150
ABC-TC1283WEHI 3BD
ABL-TC0742WEHI-3b
C12441-1mgWEHI-539
ABC-TC1285WEHI-164

Popular Products